معرفی
Michael Rehman is an Associate Research Scientist in Nephrology at Yale School of Medicine, specializing in the genetics and molecular biology of polycystic kidney diseases. His work employs mouse models and in vitro systems to study disease mechanisms. He holds a PhD in Natural Sciences from Ludwig Maximilian University. Key research interests include polycystin signaling pathways, cilia biology, and therapeutic interventions for kidney diseases. His recent studies focus on identifying molecular modifiers of cyst progression in autosomal dominant polycystic kidney disease (ADPKD), with findings published in high-impact journals like Cell Death & Disease and Nature Communications. Collaborative projects involve drug screening for antifibrotic agents and exploring the role of miRNAs in lung fibrosis. Rehman is affiliated with the Somlo Laboratory and contributes to interdisciplinary teams investigating kidney disease pathogenesis and therapy development.
